LUMO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 May 2024 @ 15:17):

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders...

Stats
Today's Volume	41 390.00
Average Volume	29 791.00
Market Cap	20.71M
EPS	$0 ( 2024-05-15 )
Next earnings date	( $-0.420 ) 2024-08-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.610
ATR14	$0.0300 (1.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-04	Pitukcheewanont Pisit Duke	Sell	0	Common Stock
2023-06-01	Pitukcheewanont Pisit Duke	Sell	29 750	Stock Option (Right to Buy)
2024-02-01	Pitukcheewanont Pisit Duke	Sell	3 333	Stock Option (Right to Buy)
2024-07-01	Pitukcheewanont Pisit Duke	Sell	25 500	Stock Option (Right to Buy)
2023-08-01	Mckew John C.	Sell	1 593	Common Stock

INSIDER POWER
24.23
Last 99 transactions
Buy: 596 623 \| Sell: 145 033

Volume Correlation

Long: -0.10 (neutral)

Short: -0.95 (very strong negative)

Signal:(64.367) Neutral

Lumos Pharma Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lumos Pharma Inc Correlation - Currency/Commodity

0.14
( neutral )

-0.69
( moderate negative )

0.00
( neutral )

-0.77
( moderate negative )

-0.26
( neutral )

0.31
( neutral )

Lumos Pharma Inc Financials

Annual	2023
Revenue:	$2.05M
Gross Profit:	$2.01M (97.85 %)
EPS:	$-4.18

FY	2023
Revenue:	$2.05M
Gross Profit:	$2.01M (97.85 %)
EPS:	$-4.18

FY	2022
Revenue:	$1.52M
Gross Profit:	$1.47M (96.78 %)
EPS:	$-3.71

FY	2021
Revenue:	$230.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.00365

Financial Reports:

No articles found.

Lumos Pharma Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Lumos Pharma Inc